The New Loan will be secured by the long-term assets of LSL Pharma’s subsidiary, Steri-Med Pharma, and bear interest at the BDC base rate plus 1.5% (the “Rate”). The Rate may be reduced by up to 2.5% ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
We couldn't find what you’re looking for right now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback